The CIN framework assigns GrowGeneration a Neutral rating at 49/100, with conviction of 1 out of 5. Fundamentals carry 35 percent of the model, regulatory posture 25, market signal 25, and editorial density 15, with every pillar contribution auditable. Regulatory leads the pillar table at 64, and is the main lever behind the Neutral conclusion. The offset comes from editorial at 30, which pulls the composite toward the middle of the band.
Under the hood, the data points sit as follows: reported revenue growth of 7.5 percent year over year, an operating margin of -13.7 percent, a market cap near 90 million, a filing cadence of 4 regulator events in the trailing 90 days. Each of those figures ties back to a specific input in the pillar breakdown. All inputs are drawn from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage density. Because every ticker in the CIN universe is scored on the same 336-name basis, GrowGeneration slots into a direct comparison rather than a bespoke narrative, and the score refreshes on the primary-source ingest cadence.
Regulatory posture is where the rating breathes. That pillar contributes 64, and a step-up in filing frequency without any enforcement activity would be the cleanest catalyst for a tighter reading.
Bullish and Bearish Analyst Opinions for GrowGeneration (GRWG)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for GrowGeneration (GRWG), a cannabis-sector equity listed on NASDAQ in the Ancillary category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
Analyst average price target $2.0.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, net loss. (2 bullish signals, 3 bearish signals.)
Bullish and bearish analyst opinions for GrowGeneration (GRWG)
Bullish view. GrowGeneration is the largest specialty hydroponic and organic gardening retailer in North America with a national footprint serving licensed cultivators; bulls model earnings recovery as US cannabis reform unlocks new state programs and cultivator capex resumes.
Bearish view. Bearish views focus on the multi-year revenue contraction as commercial cultivation overbuilt in the 2020-2022 cycle, store closures, and the correlation between GRWG top line and cannabis-operator capex which remains subdued.
Leading hydroponic and organic gardening supplies retailer serving commercial and home growers.
Latest price: $1.49 (-0.34%) on NASDAQ.
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for GRWG are maintained by Cannabis Investor News and refreshed throughout the trading day.